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Abstract 
Missing outcome data can invalidate the results of randomized trials and their meta-
analysis. The impact of missing outcome data on the summary effect can be explored by 
assuming a relationship between the outcome in the observed and the missing participants 
via an informative missingness parameter (IMP). The use of IMPs in pairwise meta-analysis 
has been previously implemented in Stata with the metamiss command for the case of 
binary outcome data. This paper presents the new command metamiss2, which is an 
extension of metamiss for binary or continuous data in pairwise or network meta-analysis. 
1. Introduction 
Missing outcome data are a common threat to the validity of randomized trials and, 
subsequently, their meta-analysis. Because missing data are by definition not present in the 
data set, addressing them requires making untestable assumptions. Researchers typically 
ignore missing data and analyse complete data only, which is equivalent to assuming that 
missing participants are missing at random (MAR) (Little and Rubin, 2014); we refer to such 
an analysis as an available cases analysis (ACA). However, this approach can give biased 
results when missingness is associated with the actual outcome. This is the case of data 
missing not at random (MNAR).  
Here we consider randomized trials with an outcome measured at a single time point, for 
which outcome data are unavailable for some of the participants within the trial. 
Furthermore, we focus on approaches that are based on aggregated (summary) data from 
the trial, such as are often available from journal articles, and which are typical of the data 
available for a meta-analysis.  
The use of pattern mixture models has been previously suggested for handling missing 
outcome data in meta-analysis of binary outcomes with aggregate data (White et al., 
2008a). This approach is based on the informative missingness odds ratio (IMOR), which 
relates the odds of outcome in the missing data to that in the observed data. The approach 
can allow for uncertainty in the IMOR, and has been implemented in Stata in the metamiss 
command.  
Parameters like the IMOR that measure departure from a MAR assumption have been 
called "sensitivity parameters" by Kenward et al (2001); we follow White et al (2011) in 
calling them "informative missingness parameters" (IMPs). Mavridis et al. extended the IMP 
framework to meta-analyses with continuous outcomes by defining IMPs that relate the 
mean of the outcome between the missing and the observed participants (Mavridis et al., 
2015).  
Network meta-analysis (NMA) combines the results of multiple direct comparisons (Salanti 
et al., 2008) and is therefore prone to the same biases as pairwise meta-analysis. More 
specifically, incorrectly handling missing data in one or more comparisons of a NMA could 
affect all relative effects in which this particular comparison is involved either directly or 
indirectly (Salanti et al., 2014). Methods used to allow for IMPs in pairwise MA apply directly 
to NMA when only two-group trials are included. In the presence of multi-group trials the 
‘adjusted’ covariance between relative effects from the same study also needs to be 
estimated (Mavridis et al., 2015). The application of IMPs in NMA with binary outcome data 
has been exemplified in a Bayesian framework by Spineli et al (Spineli et al., 2013).       
The aim of this paper is to introduce a new Stata command, called metamiss2, with new 
syntax, which extends metamiss (1) by handling continuous as well as binary outcome 
data and (2) by working in NMA as well as pairwise meta-analysis. metamiss2 performs a 
two-stage approach: stage 1 estimates the ‘adjusted’ study-specific relative effects and their 
variances and covariances, and stage 2 calls metan (Harris et al., 2008) (for pairwise meta-
analysis) or network meta (White, 2015) (for NMA) to obtain the summary effects.  
2. Theory 
This section describes stage 1 of the analysis, which estimates the treatment effect(s) and 
their variance(s) for each study allowing for MNAR data. The second stage combines the 
first-stage estimates: this is a standard meta-analysis procedure (Palmer and Sterne, 2016) 
and is not further described here. We describe first the case of two-group studies and then 
the extension for multi-group studies. 
2.1. Two-group studies 
Our notation follows that of (Mavridis et al., 2015), but is extended to cover the case of 
binary data as in (White et al., 2008a). We assume we have data from multiple studies, 
each with two groups denoted 𝑇 (treatment) and 𝐶 (control). We assume that in the 𝑗th 
group of the 𝑖th study (𝑗 = 𝐶, 𝑇), we know 𝑛𝑖𝑗, the number of participants providing outcome 
data, and 𝑚𝑖𝑗, the number of participants with missing outcome data. If the outcome is 
binary we assume we know 𝑟𝑖𝑗, the number of observed successes. If the outcome is 
continuous we assume we know 𝑥𝑖𝑗
𝑜𝑏𝑠, the mean of the observed outcomes, and 𝑠𝑖𝑗, the 
standard deviation (SD) of the observed outcomes. 
The model for the observed data is 𝑟𝑖𝑗~𝐵𝑖𝑛(𝑛𝑖𝑗, 𝜒𝑖𝑗
𝑜𝑏𝑠) if the outcome is binary and 
𝑥𝑖𝑗
𝑜𝑏𝑠~𝑁(𝜒𝑖𝑗
𝑜𝑏𝑠, 𝑠𝑖𝑗
2 ) if the outcome is continuous. In both cases 𝜒𝑖𝑗
𝑜𝑏𝑠 is the true mean of the 
observed outcomes in the 𝑗th group of the 𝑖th study. 
Our measure of interest in the 𝑖th study is defined as 𝛽𝑖 = 𝑓(𝜒𝑖𝑇
𝑡𝑜𝑡) − 𝑓(𝜒𝑖𝐶
𝑡𝑜𝑡), where 𝜒𝑖𝑗
𝑡𝑜𝑡 is 
the true mean outcome of all (observed and missing) outcomes in the 𝑗th group of the 𝑖th 
study. For a binary outcome, the link function 𝑓 may be the identity function 𝑓(𝑥) = 𝑥 (so 
that the measure of interest is the risk difference), the logarithmic function 𝑓(𝑥) = log(𝑥) 
(giving the log risk ratio) or the logit function  𝑓(𝑥) = 𝑙𝑜𝑔𝑖𝑡(𝑥) (giving the log odds ratio). For 
a continuous outcome, 𝑓 may be the identity function 𝑓(𝑥) = 𝑥 (giving the mean difference 
(MD)) or the logarithmic function 𝑓(𝑥) = log(𝑥)  (giving the log ratio of means (RoM)); 
alternatively, 𝑓(𝜒) may be replaced by 𝑓𝑖(𝜒) = 𝜒/𝜎𝑖 where 𝜎𝑖 is the pooled SD in the 𝑖th 
study, giving the standardised mean difference (SMD) (White and Thomas, 2005).  
In this simple setting, a MAR assumption would state that 𝜒𝑖𝑗
𝑡𝑜𝑡 = 𝜒𝑖𝑗
𝑜𝑏𝑠, which would justify 
ignoring the missing data (Little and Rubin, 2014). Under MNAR, we cannot ignore the 
missing data. Instead we view the mean outcome of all participants as a mixture of 
outcomes in the observed and in the missing participants. We write 𝜒𝑖𝑗
𝑡𝑜𝑡 = 𝜋𝑖𝑗𝜒𝑖𝑗
𝑜𝑏𝑠 + (1 −
𝜋𝑖𝑗)𝜒𝑖𝑗
𝑚𝑖𝑠 where 𝜋𝑖𝑗 is the probability of observed data and 𝜒𝑖𝑗
𝑚𝑖𝑠 is the (unobserved) mean 
outcome in the missing data. We introduce the IMP as 𝜆𝑖𝑗 = 𝑔(𝜒𝑖𝑗
𝑚𝑖𝑠) − 𝑔(𝜒𝑖𝑗
𝑜𝑏𝑠). For a binary 
outcome, we consider the case where 𝑔 is the logit function 𝑔(𝑥) = logit (𝑥) and the IMP is 
the log of IMOR (White et al., 2008a). For a continuous outcome, 𝑔 may be the identity 
function 𝑔(𝑥) = 𝑥 (so the IMP is the informative missingness difference of means, IMDoM), 
or the logarithmic function 𝑔(𝑥) = log(𝑥) (so the IMP is the log of the informative 
missingness ratio of means, log IMRoM) (Mavridis et al., 2015). We generally expect 
researchers to employ IMDoM with MD and SMD and IMRoM with RoM. When 𝜆𝑖𝑗 = 0, we 
assume that the outcome in the missing participants is on average the same with the 
outcome in the observed outcomes. This is equivalent to assuming that we can safely 
ignore the missing data, which is the MAR assumption. We quantify departures from the 
MAR assumption by allowing 𝜆𝑖𝑗 to assume non-zero values. 
The IMPs 𝜆𝑖𝑗 are required to estimate 𝛽𝑖 but are not identified by the observed data. 
Instead, they are either specified by the analyst on the basis of subject-matter knowledge or 
a range of values is assumed in a sensitivity analysis. By allowing for uncertainty in the 
IMPs, the model reduces the relative weight given to studies with more missing data (White 
et al., 2008a). The IMPs may be independent across groups, 𝜆𝑖𝑗~𝑁 (𝜇𝜆𝑖𝑗 , 𝜎𝜆𝑖𝑗
2 ), or we can 
allow for correlation by assuming a bivariate normal distribution with 𝑐𝑜𝑟𝑟(𝜆𝑖𝑇 , 𝜆𝑖𝐶) = 𝜌𝜆𝑖. 
Thus, non-zero values of any of 𝜇𝜆𝑖𝑇 , 𝜇𝜆𝑖𝐶 , 𝜎𝜆𝑖𝑇
2 , 𝜎𝜆𝑖𝐶
2  imply MNAR. IMPs are assumed to be 
independent across studies to abide by the fundamental assumption of independent studies 
in meta-analysis.  
Two estimation procedures are described briefly here and in more detail in Mavridis et al 
(2015). We write 𝛽𝑖 = 𝛽𝑖(𝜃𝑖) where 𝜃𝑖 = (𝜋𝑖𝑇 , 𝜋𝑖𝐶 , 𝜒𝑖𝑇
𝑜𝑏𝑠, 𝜒𝑖𝐶
𝑜𝑏𝑠, 𝜆𝑖𝑇 , 𝜆𝑖𝐶). In the Taylor method, 
which uses a linear approximation to 𝛽𝑖(𝜃𝑖), the point estimate of 𝛽𝑖 is ?̂?𝑖 = 𝛽𝑖(𝜃𝑖) where 
𝜃𝑖 = (?̂?𝑖𝑇 , ?̂?𝑖𝐶 , ?̂?𝑖𝑇
𝑜𝑏𝑠, ?̂?𝑖𝐶
𝑜𝑏𝑠, 𝜇𝜆𝑖𝑇 , 𝜇𝜆𝑖𝐶), and its estimated variance is 𝑣𝑎?̂?(?̂?𝑖) = 𝐷𝑖
𝑇𝑉𝑖𝐷𝑖 where 
𝐷𝑖 =
𝑑𝛽𝑖
𝑑𝜃𝑖
 evaluated at 𝜃𝑖 = 𝜃𝑖 and 𝑉𝑖 = 𝑣𝑎?̂?(𝜃𝑖) relates to the sampling variance for 
?̂?𝑖𝑇 , ?̂?𝑖𝐶 , ?̂?𝑖𝑇
𝑜𝑏𝑠, ?̂?𝑖𝐶
𝑜𝑏𝑠 and the uncertainty variance for 𝜇𝜆𝑖𝑇 , 𝜇𝜆𝑖𝐶. In the parametric bootstrap 
method, which avoids the linear approximation to 𝛽𝑖(𝜃𝑖), values 𝜃𝑖
∗ are repeatedly drawn - 
𝜋𝑖𝑇 , 𝜋𝑖𝐶 , 𝜒𝑖𝑇
𝑜𝑏𝑠, 𝜒𝑖𝐶
𝑜𝑏𝑠 independently from their posterior distributions given the data, and 𝜆𝑖𝑇 , 𝜆𝑖𝐶 
jointly from their prior distribution - and the point estimate ?̂? and its estimated variance are 
the mean and variance of the 𝛽𝑖(𝜃𝑖
∗). When the measure of interest is the SMD, the 
procedure takes 𝜎𝑖 as the pooled SD across groups and ignores uncertainty in 𝜎𝑖. 
2.2. Multi-group studies 
The same methods are used for multi-group studies, which may arise in network meta-
analysis. Multi-group studies yield multiple treatment effects, e.g. 𝛽𝑖1 = 𝑓(𝜒𝑖𝑇1
𝑡𝑜𝑡) − 𝑓(𝜒𝑖𝐶
𝑡𝑜𝑡) 
and 𝛽𝑖2 = 𝑓(𝜒𝑖𝑇2
𝑡𝑜𝑡) − 𝑓(𝜒𝑖𝐶
𝑡𝑜𝑡). Extending the estimation method above yields estimates of 
their variances and the covariance 𝑐𝑜𝑣(?̂?𝑖1, ?̂?𝑖2) (Mavridis et al., 2015).  
3. Syntax 
metamiss2 [varlist] [if exp] [in range] [, imptype(imdom|logimrom) 
impmean(# #...#) impsd(# #...#) impcorrelation(real|exp|matrix) 
fixed inconsistency md smd rom or rr rd sdpool(on|off) taylor 
bootstrap reps(integer) compare(string) sensitivity nokeep nometa 
varchange netplot trtlabels(string) metanoptions(meta_options) 
networkoptions(network_meta_options) netplotreference(string) 
netplotoptions(intervalplot_options)] 
where varlist is: 
- for pairwise meta-analysis with continuous outcome data: nE mE yE sdE nC mC yC sdC - 
variables containing the numbers of observed and missing participants, the mean and 
SD of the observed data in experimental and control group respectively. 
- for pairwise meta-analysis with dichotomous outcome data:  rE fE mE rC fC mC - 
variables containing the numbers of successes and failures in the observed data and 
the number of missing participants in experimental and control group respectively. 
- for network meta-analysis:  varlist is not used but the data must have been prepared 
using the network setup command (White, 2015) in the augmented format (see 
example 4.3). 
Options for specifying the IMPs 
imptype(imdom|logimrom) specifies the type of IMP for continuous outcome data. The 
default is imdom. This option is not needed for dichotomous outcome data since the only 
available IMP is logimor. 
impmean(exp exp...exp) specifies the mean of the assumed (normal) distribution for 
IMP. The default value is 0 in all groups.  If one value is given, it is the mean for all groups. 
For pairwise meta-analysis, if two values are given, they are the means for the experimental 
and control group.  For network meta-analysis, if 𝑇 values are given (with 𝑇 the total 
number of treatments), they are the means for the reference treatment and the non-
reference treatments in the order shown in network setup. Each exp may be a single 
value corresponding to all studies or a variable containing study-specific values. 
impsd(exp exp...exp) specifies the SD of the assumed (normal) distribution for IMP in 
the same way as described above for impmean().  The default value is 0 in all groups. 
impcorrelation(real|exp|matrix) specifies the correlation of the IMP between the 
different groups. The default value is 0.  A common correlation value for all pairs of 
treatments or the full 𝑇 × 𝑇 correlation matrix (only for network meta-analysis) can be 
specified. 
compare(string) specifies a second assumption for IMP to be compared to the primary 
analysis. string may include impmean(), impsd() and impcorrelation(). 
sensitivity specifies a sensitivity analysis for the IMP assuming a range of different 
standard deviations for its distribution with impmean(0) or a different specified 
impmean(). 
Options for continuous data 
smd specifies the standardized mean difference as the measure of interest (the default for 
continuous data). 
md specifies the mean difference as the measure of interest. 
rom specifies the ratio of means as the measure of interest. 
sdpool(on|off) specifies whether the SD is pooled across groups in computing 
variances.  Following metan, the default option for mean difference and ratio of means is 
sdpool(off) and for standardized mean difference is sdpool(on). 
Options for dichotomous data 
rr specifies the risk ratio (RR) as the measure of interest (the default for dichotomous 
data). Note that in this case the IMP is the logimor. 
or specifies the odds ratio as the measure of interest.  Note that in this case the IMP is the 
logimor.  
rd specifies the risk difference as the measure of interest.  Note that in this case the IMP is 
logimor. 
Estimation options 
taylor specifies that Taylor-series approximation is used to integrate over the distribution 
of the IMP (the default). 
bootstrap specifies that parametric bootstrap is used to integrate over the distribution of 
the IMP. 
reps(integer) specifies the number of simulations under the bootstrap method. The 
default is 10000. 
Meta-analysis options 
fixed specifies the use of the fixed-effect model instead of the default random-effects 
model. 
inconsistency specifies the use of an inconsistency model for the case of network meta-
analysis instead of the consistency model which is the default. 
nometa skips the conduct of pairwise or network meta-analysis after estimating the 
‘adjusted’ study-specific effect sizes and variances. 
metanoptions(meta_options) are any valid options for metan. 
networkoptions(network_meta_options) are any valid options for network meta. 
Output options 
nokeep specifies that study-specific ‘adjusted’ effect sizes and standard errors/variances 
will be dropped from the dataset. By default, these estimates are stored as extra variables; 
for pairwise meta-analysis with names _ES, _seES (as in metan) and in network meta-
analysis with prefix _imp_. 
varchange specifies that the ‘adjusted’ study-specific relative effects and variances are 
stored in the dataset replacing the respective values obtained from the network setup 
command. This means that the current assumptions about the missing data will also apply 
to future analyses of the data. 
netplot specifies that a forest plot with the relative effects from network meta-analysis will 
be drawn. The same forest plot can be produced by running the intervalplot command 
(Chaimani and Salanti, 2015) after metamiss2 for a network meta-analysis. Note that for 
the case of pairwise meta-analysis a forest plot is produced by default. 
trtlabels(string) specifies the labels of the treatments for the case of network meta-
analysis separated with spaces. These labels will be used in netplot. The first label 
should correspond to the reference treatment and the other treatment should be given in 
the numerical/alphabetical order of their codes in the data. 
netplotreference(string) specifies a treatment to be used as reference in the 
netplot so as only a subset of the relative effects from the network meta-analysis (i.e. 
every treatment vs. that reference) will be given in the forest plot. The treatment specified 
here can be different from the reference treatment of the analysis. 
netplotoptions(intervalplot_options) specifies any additional valid option 
allowed in intervalplot. 
4. Examples 
4.1. Pairwise meta-analysis, binary data 
We illustrate the use of metamiss2 for pairwise meta-analysis with binary outcome data 
using a dataset that includes 17 trials comparing the effectiveness of haloperidol against 
placebo for the treatment of schizophrenia. The outcome is clinical response and RR>1 
suggest that haloperidol works better that placebo.  
. li,clean noo 
           author   year   rh   fh   mh   rp   fp   mp   
        Arvanitis   1997   25   25    2   18   33    0   
          Beasley   1996   29   18   22   20   14   34   
         Bechelli   1983   12   17    1    2   28    1   
          Borison   1992    3    9    0    0   12    0   
        Chouinard   1993   10   11    0    3   19    0   
           Durost   1964   11    8    0    1   14    0   
            Garry   1962    7   18    1    4   21    1   
           Howard   1974    8    9    0    3   10    0   
           Marder   1994   19   45    2   14   50    2   
     Nishikawa_82   1982    1    9    0    0   10    0   
     Nishikawa_84   1984   11   23    3    0   13    0   
          Reschke   1974   20    9    0    2    9    0   
           Selman   1976   17    1   11    7    4   18   
    Serafetinides   1972    4   10    0    0   13    1   
          Simpson   1967    2   14    0    0    7    1   
          Spencer   1992   11    1    0    1   11    0   
         Vichaiya   1971    9   20    1    0   29    1   
 
We explore different assumptions about the association of the outcome between missing 
and observed data, which we describe by the 𝑙𝑜𝑔𝐼𝑀𝑂𝑅.  
First, we assume that our beliefs about the missing data can be expressed as follows. In 
the haloperidol group we believe there may be systematic differences between outcomes in 
missing and observed participants but we are not sure in which direction, so we give the 
𝑙𝑜𝑔𝐼𝑀𝑂𝑅 a distribution with mean 0 and SD 1. In the placebo group we believe the 
response in missing participants is probably worse than in observed participants, so we 
give the 𝑙𝑜𝑔𝐼𝑀𝑂𝑅 a distribution with mean -1 and SD 1. This can be the case when for 
example patients dropout the study because their symptoms have worsen.  We use the 
default method of estimation, which is Taylor-series approximation. We use the metan 
options lcols(author) to label the studies.  
    
. metamiss2 rh fh mh rp fp mp, impmean(0 -1) impsd(1) metanopt(lcols(author)) 
 
******************************************************************* 
******** METAMISS2: meta-analysis allowing for missing data ******* 
******** Informative missingness parameter with uncertainty ******* 
******************************************************************* 
 
Informative missingness parameter: logIMOR 
Measure of interest:               Risk ratio 
Assumed distribution for IMP:      Experimental group ~ N(0,1^2) 
  Control group ~ N(-1,1^2) 
IMP correlation between groups:    0 
Method for first stage model:      Taylor series approximation 
Second stage model:                Random effects meta-analysis 
 
(Calling metan with options: lcols(author) ...) 
 
           Study     |     ES    [95% Conf. Interval]     % Weight 
---------------------+--------------------------------------------------- 
Arvanitis            |  1.417       0.890     2.256         18.58 
Beasley              |  1.323       0.720     2.432         14.50 
Bechelli             |  6.333       1.547    25.918          4.39 
Borison              |  7.000       0.400   122.442          1.19 
Chouinard            |  3.492       1.113    10.955          6.21 
Durost               |  8.684       1.258    59.946          2.51 
Garry                |  1.791       0.596     5.381          6.60 
Howard               |  2.039       0.670     6.208          6.48 
Marder               |  1.381       0.758     2.517         14.72 
Nishikawa_82         |  3.000       0.137    65.903          1.03 
Nishikawa_84         |  9.200       0.580   146.044          1.28 
Reschke              |  3.793       1.058    13.604          5.19 
Selman               |  1.949       0.906     4.194         11.09 
Serafetinides        |  8.764       0.516   148.917          1.22 
Simpson              |  2.526       0.135    47.152          1.14 
Spencer              | 11.000       1.671    72.396          2.62 
Vichaiya             | 19.393       1.180   318.749          1.25 
---------------------+--------------------------------------------------- 
D+L pooled ES        |  2.211       1.607     3.042        100.00 
---------------------+--------------------------------------------------- 
 
  Heterogeneity chi-squared =  20.66 (d.f. = 16) p = 0.192 
  I-squared (variation in ES attributable to heterogeneity) =  22.6% 
  Estimate of between-study variance Tau-squared =  0.0863 
 
  Test of ES=1 : z=   4.87 p = 0.000 
 
After running metamiss2 the ‘adjusted’ study-specific relative effects along with their 95% 
confidence intervals are given in the output. The same results are obtained when we run 
the same analysis with metamiss: 
. metamiss rh fh mh rp fp mp, logimor(0 -1) sdlogimor(1) method(Taylor) randomi 
lcols(author)  
 
 
******************************************************************* 
******** METAMISS: meta-analysis allowing for missing data ******** 
********           Bayesian analysis using priors          ******** 
******************************************************************* 
Measure: RR. 
Zero cells detected: adding 1/2 to 6 studies. 
Priors used:  Group 1: N(0,1^2). Group 2: N(-1,1^2). Correlation: 0. 
Method: Taylor series approximation. 
 
(Calling metan with options:  randomi lcols(author) eform  ...) 
 
{output omitted} 
 
The above analysis implicitly assumes that the IMPs in the two groups are unrelated. We 
next assume that a high 𝑙𝑜𝑔𝐼𝑀𝑂𝑅 in one group is likely to go with a high 𝑙𝑜𝑔𝐼𝑀𝑂𝑅 in the 
other group; that entails  the two 𝑙𝑜𝑔𝐼𝑀𝑂𝑅s are positively correlated, with correlation 𝜌 =
0.5. We obtain the study-specific RRs using the bootstrap method: 
. metamiss2 rh fh mh rp fp mp, impmean(0 -1) impsd(1) impc(0.5) b metanopt(lcols(author)) 
 
******************************************************************* 
******** METAMISS2: meta-analysis allowing for missing data ******* 
******** Informative missingness parameter with uncertainty ******* 
******************************************************************* 
 
Informative missingness parameter: logIMOR 
Measure of interest:               Risk ratio 
Assumed distribution for IMP:      Experimental group ~ N(0,1^2) 
  Control group ~ N(-1,1^2) 
IMP correlation between groups:    0.5 
Method for first stage model:      Parametric Bootstrap (10000 draws) 
Second stage model:                Random effects meta-analysis 
 
(Calling metan with options: lcols(author) ...) 
 
           Study     |     ES    [95% Conf. Interval]     % Weight 
---------------------+--------------------------------------------------- 
Arvanitis            |  1.426       0.888     2.290         17.68 
Beasley              |  1.298       0.760     2.217         16.40 
Bechelli             |  7.898       1.600    38.975          4.52 
Borison              | 21.875       0.258   1853.641         0.70 
Chouinard            |  3.959       1.133    13.836          6.60 
Durost               | 14.440       1.218   171.198          2.11 
Garry                |  1.888       0.580     6.149          7.17 
Howard               |  2.275       0.668     7.741          6.81 
Marder               |  1.398       0.760     2.574         14.92 
Nishikawa_82         |  7.395       0.073   744.881          0.65 
Nishikawa_84         | 30.602       0.406   2306.082         0.73 
Reschke              |  4.733       1.108    20.229          5.26 
Selman               |  1.973       0.919     4.236         12.19 
Serafetinides        | 26.937       0.348   2082.840         0.72 
Simpson              |  6.696       0.077   579.813          0.69 
Spencer              | 18.484       1.575   216.868          2.13 
Vichaiya             | 67.066       0.852   5281.565         0.72 
---------------------+--------------------------------------------------- 
D+L pooled ES        |  2.342       1.609     3.411        100.00 
---------------------+--------------------------------------------------- 
 
  Heterogeneity chi-squared =  23.53 (d.f. = 16) p = 0.100 
  I-squared (variation in ES attributable to heterogeneity) =  32.0% 
  Estimate of between-study variance Tau-squared =  0.1496 
 
  Test of ES=1 : z=   4.44 p = 0.000 
 
Running the same analysis with metamiss gives slightly different results: 
. metamiss rh fh mh rp fp mp, logimor(0 -1) sdlogimor(1) corrlogimor(0.5) method(mc) 
randomi lcols(author) reps(10000)  
******************************************************************* 
******** METAMISS: meta-analysis allowing for missing data ******** 
********           Bayesian analysis using priors          ******** 
******************************************************************* 
Measure: logRR. 
Zero cells detected: adding 1/2 to 6 studies. 
Priors used:  Group 1: N(0,1^2). Group 2: N(-1,1^2). Correlation: 0.5. 
Method: Monte Carlo (10000 draws). 
..........................................................................................
>......................................................................................... 
{output omitted} 
 
(Calling metan with options:  randomi lcols(author) eform  ...) 
 
           Study     |     ES    [95% Conf. Interval]     % Weight 
---------------------+--------------------------------------------------- 
Arvanitis            |  1.420       0.891     2.263         17.10 
Beasley              |  1.302       0.763     2.221         14.92 
Bechelli             |  5.322       1.504    18.828          4.32 
Borison              |  4.025       0.523    30.955          1.81 
Chouinard            |  3.173       1.106     9.105          5.87 
Durost               |  6.204       1.325    29.046          3.03 
Garry                |  1.736       0.619     4.864          6.09 
Howard               |  1.948       0.684     5.551          5.93 
Marder               |  1.374       0.762     2.477         13.38 
Nishikawa_82         |  2.046       0.225    18.563          1.56 
Nishikawa_84         |  5.125       0.757    34.711          2.04 
Reschke              |  3.495       1.113    10.975          5.12 
Selman               |  1.953       0.924     4.129          9.85 
Serafetinides        |  4.822       0.676    34.407          1.94 
Simpson              |  1.661       0.214    12.870          1.80 
Spencer              |  7.757       1.740    34.584          3.21 
Vichaiya             |  9.990       1.477    67.586          2.04 
---------------------+--------------------------------------------------- 
D+L pooled ES        |  2.143       1.616     2.842        100.00 
---------------------+--------------------------------------------------- 
 
  Heterogeneity chi-squared =  20.16 (d.f. = 16) p = 0.213 
  I-squared (variation in ES attributable to heterogeneity) =  20.6% 
  Estimate of between-study variance Tau-squared =  0.0648 
 
  Test of ES=1 : z=   5.29 p = 0.000 
 
This difference in results is due to a) random error of the simulations and b) the different 
way the two commands handle studies without missing participants in one or both groups. 
More specifically, for these trials metamiss2 assumes that the probability of observing the 
data is 𝜋𝑖𝑗 = 1, while metamiss assumes that the probability is not constant but a random 
variable.    
An important advantage of metamiss2 when using the bootstrap method is that it runs 
much faster (i.e. about 10 times) than metamiss due to coding in mata. 
 
4.2. Pairwise meta-analysis, continuous data 
The second example involves data from 8 trials that compare the effectiveness of 
mirtazapine versus placebo for major depression. The outcome is change in depression 
symptoms measured on a standardized rating scale (the HAMD21 scale). 
. li,clean noo 
    id          study      yp    sdp   np   mp      ym   sdm   nm   mm   
     1   Claghorn1995   -11.4   10.2   19   26   -14.5   8.8   26   19   
     2    MIR 003-003   -11.5    8.3   24   21     -14   7.3   27   18   
     3    MIR 003-008   -11.4      8   17   13   -13.2     8   12   18   
     4    MIR 003-020    -6.2    6.5   24   19     -13     9   23   21   
     5    MIR 003-021   -17.4    5.3   21   29   -13.8   5.9   22   28   
     6    MIR 003-024   -11.1    9.9   27   23   -15.7   6.7   30   20   
     7     MIR 84023a   -11.9    8.6   33   24   -14.2   7.6   35   25   
     8     MIR 84023b   -11.8    8.3   48   18   -14.7   8.4   51   13   
 
 
We first describe the departure from MAR using the 𝐼𝑀𝐷𝑂𝑀. We assume a systematic 
departure from the MAR assumption where for the mirtazapine group 𝐼𝑀𝐷𝑂𝑀 has mean 
−0.5 with 𝑠𝑑(𝐼𝑀𝐷𝑂𝑀) = 1 and for the placebo group 𝐼𝑀𝐷𝑂𝑀 has mean 
1 with 𝑠𝑑(𝐼𝑀𝐷𝑂𝑀) = 1.5. This means that we think it likely that missing participants had 
better outcomes than observed participants in the mirtazapine group (e.g. they left the study 
because of early response with important side effects) while the opposite is true in the 
placebo group (e.g. they left the study because of lack of efficacy). We also assume that 
𝐼𝑀𝐷𝑂𝑀s are correlated between the two groups with 𝜌 = 0.5 and we compare the results 
with ACA (i.e. when IMP=0 without uncertainty): 
. metamiss2 nm mm ym sdm np mp yp sdp, impmean(-0.5 1) impsd(1 1.5) impcorr(0.5) 
compare(impmean(0) impsd(0)) md metanopt(lcols(study)) 
 
Primary analysis 
 
******************************************************************* 
******** METAMISS2: meta-analysis allowing for missing data ******* 
******** Informative missingness parameter with uncertainty ******* 
******************************************************************* 
 
Informative missingness parameter: IMDOM 
Measure of interest:               Mean difference 
Assumed distribution for IMP:      Experimental group ~ N(-0.5,1^2) 
  Control group ~ N(1,1.5^2) 
IMP correlation between groups:    0.5 
Method for first stage model:      Taylor series approximation 
Second stage model:                Random effects meta-analysis 
 
(Calling metan with options: lcols(study)...) 
 
Secondary analysis 
  
 
 
******************************************************************* 
******** METAMISS2: meta-analysis allowing for missing data ******* 
********               Available cases analysis            ******** 
******************************************************************* 
 
Informative missingness parameter: IMDOM 
Measure of interest:               Mean difference 
Method for first stage model:      Taylor series approximation 
Second stage model:                Random effects meta-analysis 
 
(Calling metan with options: lcols(study)...) 
 
           Study     |     ES    [95% Conf. Interval]      
---------------------+--------------------------------------------------- 
     Primary analysis 
1                    |   -3.889    -9.783     2.005         
2                    |   -3.167    -7.653     1.319         
3                    |   -2.533    -8.583     3.516         
4                    |   -7.480   -12.143    -2.818         
5                    |    2.740    -0.940     6.420         
6                    |   -5.260    -9.860    -0.660         
7                    |   -2.929    -6.956     1.097         
8                    |   -3.274    -6.645     0.096         
 Sub-total           | 
  D+L pooled ES      |   -3.046    -5.264    -0.828         
---------------------+--------------------------------------------------- 
     Secondary analysis 
9                    |   -3.100    -8.799     2.599         
10                   |   -2.500    -6.814     1.814         
11                   |   -1.800    -7.712     4.112         
12                   |   -6.800   -11.305    -2.295         
13                   |    3.600     0.251     6.949         
14                   |   -4.600    -9.038    -0.162         
15                   |   -2.300    -6.166     1.566         
16                   |   -2.900    -6.191     0.391         
 Sub-total           | 
  D+L pooled ES      |   -2.382    -4.729    -0.035         
---------------------+--------------------------------------------------- 
 
Test(s) of heterogeneity: 
               Heterogeneity  degrees of 
                 statistic     freedom      P    I-squared**   Tau-squared 
 
Primary analysis    13.92          7      0.053     49.7%       4.9682 
Secondary analysis  16.92          7      0.018     58.6%       6.5355 
** I-squared: the variation in ES attributable to heterogeneity) 
 
 
Significance test(s) of ES=0 
 
Primary analysis      z=  2.69     p = 0.007 
Secondary analysis    z=  1.99     p = 0.047 
 
Next we change the IMP to the 𝐼𝑀𝑅𝑂𝑀 and run a sensitivity analysis with 𝐼𝑀𝑅𝑂𝑀 = 1 on a 
range of different values for 𝑠𝑑(𝑙𝑜𝑔𝐼𝑀𝑅𝑂𝑀) using the bootstrap method: 
. metamiss2 nm mm ym sdm np mp yp sdp, md sensitivity b imptype(logimrom) 
 
******************************************************************* 
******** METAMISS2: meta-analysis allowing for missing data ******* 
******** Informative missingness parameter with uncertainty ******* 
****    Sensitivity analysis assuming departures from MAR     ***** 
******************************************************************* 
 The graph shows that increasing the uncertainty of the IMP results into narrower confidence 
interval for the summery effect up to some point (~SD=3); this is related to the reduction of 
heterogeneity due to the extra variance introduced in the study-specific estimates. 
However, when very large uncertainty is assumed for IMP (SD>3), then this uncertainty is 
also reflected in the summary effect and therefore the confidence interval becomes wider.  
4.3. Network meta-analysis 
To exemplify the use of metamiss2 in NMA we use a dataset that comprises a network of 
12 trials comparing the effectiveness of 9 antidepressants. The outcome is again measured 
as the change score on the HAMD21 depression scale.  
. li,clean noo 
    id   t       y      sd    n     m   
     1   8     4.6    8.65   39    13   
     1   1       9    8.65   41     8   
     2   1    7.56   12.31   39     1   
     2   4   11.27   11.33   45     3   
     3   6    14.2    11.1   75    18   
     3   2    17.2    11.1   74    23   
     4   2    13.5     2.1   12    15   
     4   4    13.8     1.8   15    11   
     5   4    7.76    2.89   21     3   
     5   3    6.55    5.23   20     5   
     6   4       7       5   45     0   
     6   9       6       5   43     1   
     7   9     8.4     5.4   67    11   
     7   4     9.6     6.2   63    19   
     8   4      11    9.12   55   145   
     8   5    10.4    9.12   37   163   
     9   5    15.8     3.3   30     3   
     9   6    18.7     5.1   32     2   
    10   6     8.2    7.52   55    20   
    10   9     8.7    7.52   55    15   
    11   6    10.4    7.52   15     3   
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    11   7     7.4    7.52   16     2   
    12   9    11.3    8.65   91    37   
    12   6      12    8.65   89    32   
 
Because of the complicated structure of data, metamiss2 does not take arguments for the 
outcome when applied to NMA. Instead, the command metamiss2 shall be executed after 
the data has been set up with the network setup command. This applies to any type of 
outcome that is handled with the network setup.  
 
We first prepare the data in the ‘augmented’ format using the network package: 
. network setup y sd n, trt(t) stud(id) nmiss(m) nocodes 
{output omitted} 
 
and then run metamiss2 without arguments to obtain the ACA analysis: 
. metamiss2 
{output omitted} 
 
To explore the impact of alternative assumptions we incorporate IMPs in our analysis. As in 
pairwise meta-analysis, IMPs can be treatment-specific. There are 9 treatments in the 
network and assumptions for the outcome among missing participants can be different 
depending on the administered treatment.  Here, we consider that treatments 1, 2, 6 and 8 
are associated with 𝐼𝑀𝐷𝑂𝑀 = 1; for treatments 3, 4 and 9 𝐼𝑀𝐷𝑂𝑀 = −1 and 𝐼𝑀𝐷𝑂𝑀 = 0 
for treatments 5 and 7. We assume 𝑠𝑑(𝐼𝑀𝐷𝑂𝑀) = 1 for all treatments in the network. 
Additionally, drug-specific 𝐼𝑀𝐷𝑂𝑀𝑠 can be correlated depending on the nature of missing 
data. Information about the pairwise correlation between the 9 𝐼𝑀𝐷𝑂𝑀𝑠 has to be collected 
in a matrix. In the matrix shown below, the correlation between the 𝐼𝑀𝐷𝑂𝑀𝑠 for treatments 
4 and 6 is 𝜌4,6 = 0.5 and between treatments 5 and 6 is 𝜌5,6 = 0.2:  
𝐶 =
(
 
 
 
 
 
 
1 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.5 1 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
1
0.5
0.5
0.5
0.5
0.5
0.5
0.5
1
0.2
0.5
0.5
0.5
0.5
0.5
0.2
1
0.2
0.5
0.5
0.5
0.5
0.5
0.2
1
0.2
0.5
0.5
0.5
0.5
0.5
0.2
1
0.2
0.5
0.5
0.5
0.5
0.5
0.2
1
0.2
0.5
0.5
0.5
0.5
0.5
0.2
1 )
 
 
 
 
 
 
 
Note that here the choice of the correlation matrix is arbitrary but in practice it should be 
defined on the basis of expert opinion. 
 
The matrix can be specified using the mat command 
. mat C=J(9,9,0.5)+0.5*I(9) 
forvalues i=4/8{ 
  mat C[`i’,`=`i’+1’]=0.2 
  mat C[`=`i’+1’,`i’]=0.2 
 } 
 
. mat li C 
 
symmetric C[9,9] 
    c1  c2  c3  c4  c5  c6  c7  c8  c9 
r1   1 
r2  .5   1 
r3  .5  .5   1 
r4  .5  .5  .5   1 
r5  .5  .5  .5  .2   1 
r6  .5  .5  .5  .5  .2   1 
r7  .5  .5  .5  .5  .5  .2   1 
r8  .5  .5  .5  .5  .5  .5  .2   1 
r9  .5  .5  .5  .5  .5  .5  .5  .2   1 
 
To run the analysis, the metamiss2 command has to take three arguments; the vector of 
the  𝐼𝑀𝐷𝑂𝑀𝑠, the vector of their variances and matrix of correlations. We run the analysis 
using the bootstrap method: 
 
. metamiss2, impmean(1 1 -1 -1 0 1 0 1 -1) impsd(1) impcorr(C) b 
 
******************************************************************* 
**** METAMISS2: network meta-analysis allowing for missing data *** 
******** Informative missingness parameter with uncertainty ******* 
******************************************************************* 
 
Informative missingness parameter: IMDOM 
Measure of interest:               Mean difference 
Assumed distribution for IMP:      1 ~ N(1,1^2)  (Reference group) 
                                   2 ~ N(1,1^2) 
                                   3 ~ N(-1,1^2) 
                                   4 ~ N(-1,1^2) 
                                   5 ~ N(0,1^2) 
                                   6 ~ N(1,1^2) 
                                   7 ~ N(0,1^2) 
                                   8 ~ N(1,1^2) 
                                   9 ~ N(-1,1^2) 
IMP correlation between groups:    Matrix C 
Method for first stage model:      Parametric Bootstrap (10000 draws) 
Second stage model:                Random effects network meta-analysis 
 
(Calling network meta with options: nograph ...) 
 
Command is: mvmeta _y _S  , bscovariance(exch 0.5) longparm suppress(uv mm)  vars(_y_2 
_y_3 _y_4 _y_5 _y_6 _y_7 _y_8 _y_9) 
Note: using method reml 
Note: using variables _y_2 _y_3 _y_4 _y_5 _y_6 _y_7 _y_8 _y_9 
Note: 12 observations on 8 variables 
Note: variance-covariance matrix is proportional to .5*I(8)+.5*J(8,8,1) 
 
initial:       log likelihood = -50.831161 
rescale:       log likelihood = -50.831161 
rescale eq:    log likelihood = -50.427058 
Iteration 0:   log likelihood = -50.427058   
Iteration 1:   log likelihood =  -50.39345   
Iteration 2:   log likelihood = -50.393443   
Iteration 3:   log likelihood = -50.393443   
 
Multivariate meta-analysis 
Variance-covariance matrix = proportional .5*I(8)+.5*J(8,8,1) 
Method = reml                                  Number of dimensions    =     8 
Restricted log likelihood = -50.393443         Number of observations  =    12 
------------------------------------------------------------------------------ 
             |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
_y_2         | 
       _cons |   4.201509   2.568303     1.64   0.102    -.8322724    9.235291 
-------------+---------------------------------------------------------------- 
_y_3         | 
       _cons |   1.806593   2.776342     0.65   0.515    -3.634939    7.248124 
-------------+---------------------------------------------------------------- 
_y_4         | 
       _cons |   3.086682   2.430321     1.27   0.204    -1.676659    7.850024 
-------------+---------------------------------------------------------------- 
_y_5         | 
       _cons |   .5450634   2.709961     0.20   0.841    -4.766362    5.856489 
-------------+---------------------------------------------------------------- 
_y_6         | 
       _cons |   2.808598   2.601193     1.08   0.280    -2.289646    7.906842 
-------------+---------------------------------------------------------------- 
_y_7         | 
       _cons |  -.3568005   3.786236    -0.09   0.925    -7.777686    7.064085 
-------------+---------------------------------------------------------------- 
_y_8         | 
       _cons |  -4.303123   1.982229    -2.17   0.030     -8.18822   -.4180255 
-------------+---------------------------------------------------------------- 
_y_9         | 
       _cons |   2.046148   2.517793     0.81   0.416    -2.888636    6.980932 
------------------------------------------------------------------------------ 
 
Estimated between-studies SDs and correlation matrix: 
             SD    _y_2    _y_3    _y_4    _y_5    _y_6    _y_7    _y_8       _y_9 
_y_2  3.837e-11       1       .       .       .       .       .       .          . 
_y_3  3.837e-11      .5       1       .       .       .       .       .          . 
_y_4  3.837e-11      .5      .5       1       .       .       .       .          . 
_y_5  3.837e-11      .5      .5      .5       1       .       .       .          . 
_y_6  3.837e-11      .5      .5      .5      .5       1       .       .          . 
_y_7  3.837e-11      .5      .5      .5      .5      .5       1       .          . 
_y_8  3.837e-11      .5      .5      .5      .5      .5      .5       1          . 
_y_9  3.837e-11      .5      .5      .5      .5      .5      .5      .5          1 
mvmeta command stored as F9 
 
Accounting for missing outcome data in this particular example had little impact on the 
results, which might be due to the arbitrary assumptions we made about the IMPs. 
Treatment 8 appears to be more effective than treatment 1, as in the ACA analysis. The 
confidence intervals of all relative effects are slightly narrower compared to ACA, while 
heterogeneity was estimated to be near zero.  
5. Discussion 
metamiss2 and metamiss are almost equivalent for meta-analyses with binary outcome 
data, and they give identical answers when the Taylor series method is used to account for 
uncertainty. However, small discrepancies exist between the two commands. First, 
metamiss has the option to perform analyses of missing dichotomous data based on 
reasons for missingness  (White and Higgins, 2009). This approach allows different 
assumptions to be made within each study group at the patient level and not only on 
average as metamiss2 (Higgins et al., 2008). However, patient-level information about 
reasons for missingness is the exception rather than the norm in a meta-analysis of 
aggregated data. Second, the option to use the Gauss-Hermite quadrature estimation 
method is not available in metamiss2. However, the parametric bootstrap method in 
metamiss2 is very fast and thus it can be used routinely as an alternative to quadrature. 
Note that the Monte Carlo method which is available in metamiss is fully Bayesian and 
thus can show small numerical differences from the parametric bootstrap method in 
metamiss2. 
A limitation of metamiss2 is that finite-sample correction for SMD has not been incorporated 
in the present code; this correction allows for uncertainty in the observed study-specific 
standard deviations when trial sample sizes are small. Future work will explore the potential 
to enable an assumption that IMPs are correlated across different studies (White et al., 
2008b, p. 2).  
There is no unique best approach to handle missing outcome data in meta-analysis. ACA is 
usually a sensible starting point and will often be the primary analysis. Since the IMP 
parameters cannot be estimated from the observed data, values most be given to them 
based on judgement and on evidence external to the meta-analysis. Thus, sensitivity 
analyses using different plausible values of IMPs are necessary to assess the robustness of 
results to different assumptions about the missing data. The sensitivity option in 
metamiss2 sets the IMP means and correlation to zero and gradually increases the IMP 
standard deviations.  This reflects a minor departure from MAR. In practice, we would 
expect the IMP mean to be non-zero. We may conduct additional sensitivity analyses 
changing the value of both mean and SD (one at a time) of IMP parameters and assuming 
each of them common and different across groups, and monitor how sensitive results are to 
these changes. Other sensitivity analysis strategies were suggested by White et al (2008a). 
In all cases, discussion with subject matter experts is needed to choose sensible 
distributions for the IMPs.  
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